Results 291 to 300 of about 116,907 (303)
Some of the next articles are maybe not open access.
Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2023
Tilmann Schmidt, T. Huber
semanticscholar +1 more source
Tilmann Schmidt, T. Huber
semanticscholar +1 more source
Thrombotic Microangiopathies and the Kidney
Advances in Kidney Disease and HealthThrombotic microangiopathy (TMA) is a pathological lesion that occurs due to endothelial injury. It can be seen in a heterogenous group of disorders, typically characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end-organ ischemia. TMA can also be renal limited with no systemic manifestations.
Anuja Java +2 more
openaire +2 more sources
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics
Nature Reviews Nephrology, 2021F. Fakhouri, V. Frémeaux-Bacchi
semanticscholar +1 more source
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2006
Thrombotic microangiopathies (TMAs) are characterized by thrombocytopenia, microangiopathic hemolytic anemia, and organ failure (mostly renal dysfunction). TMA includes thrombotic thrombocytopenic purpura (TTP) with predominant neurological signs and hemolytic uremic syndrome (HUS) with predominant renal dysfunction, but they are often ...
openaire +2 more sources
Thrombotic microangiopathies (TMAs) are characterized by thrombocytopenia, microangiopathic hemolytic anemia, and organ failure (mostly renal dysfunction). TMA includes thrombotic thrombocytopenic purpura (TTP) with predominant neurological signs and hemolytic uremic syndrome (HUS) with predominant renal dysfunction, but they are often ...
openaire +2 more sources
Thrombotic microangiopathy during pregnancy.
Microvascular Research, 2021S. Z. Vahed, Y. R. Saadat, M. Ardalan
semanticscholar +1 more source
Prostacyclin and Thrombotic Microangiopathy
Seminars in Thrombosis and Hemostasis, 1980de Gaetano G +6 more
openaire +3 more sources